STRUCTURE AND TRAFFICKING OF PCSK9 IN LDL BINDING

被引：0
|
作者：
Matteucci, Sara [1 ]
Pravata, Valentina [1 ]
Esposito, Francesco Maria [1 ]
Arnaboldi, Lorenzo [2 ]
Gianazza, Erica [3 ]
Grigore, Liliana [1 ]
Banfi, Cristina [3 ]
Catapano, Alberico [1 ]
机构：
[1] IRCCS Multimed, Milan, Italy
[2] Univ Milan, Dept Pharmacol Sci Rodolfo Paoletti Disfeb, Milan, Italy
[3] IRCCS Monzino Cardiol Ctr, Milan, Italy
来源：
ATHEROSCLEROSIS | 2024年 / 395卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P220
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Effects of PCSK9 Inhibition on Plasma PCSK9 Concentration and Hepatic PCSK9 Expression
    Shapiro, Michael D.
    Tavori, Hagai
    Oleaga, Carlota
    Miles, Joshua
    Fazio, Sergio
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [32] Sorting an LDL receptor with bound PCSK9 to intracellular degradation
    Leren, Trond P.
    ATHEROSCLEROSIS, 2014, 237 (01) : 76 - 81
  • [33] Antibodies to PCSK9 A Superior Way to Lower LDL Cholesterol?
    Maxwell, Kara N.
    Breslow, Jan L.
    CIRCULATION RESEARCH, 2012, 111 (03) : 274 - 277
  • [34] Molecular biology of PCSK9: its role in LDL metabolism
    Horton, Jay D.
    Cohen, Jonathan C.
    Hobbs, Helen H.
    TRENDS IN BIOCHEMICAL SCIENCES, 2007, 32 (02) : 71 - 77
  • [35] LDL LOWERING EFFECT OF PCSK9 INHIBITION IS REDUCED IN WOMEN
    Myasoedova, V.
    Rimbert, A.
    Camera, M.
    Le May, C.
    Capoulade, R.
    Cariou, B.
    Poggio, P.
    ATHEROSCLEROSIS, 2023, 379
  • [36] Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol REPLY
    Swergold, Gary D.
    Stein, Evan A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (25): : 2426 - 2426
  • [37] Heparan sulfate proteoglycans present PCSK9 to the LDL receptor
    Camilla Gustafsen
    Ditte Olsen
    Joachim Vilstrup
    Signe Lund
    Anika Reinhardt
    Niels Wellner
    Torben Larsen
    Christian B. F. Andersen
    Kathrin Weyer
    Jin-ping Li
    Peter H. Seeberger
    Søren Thirup
    Peder Madsen
    Simon Glerup
    Nature Communications, 8
  • [38] Heparan sulfate proteoglycans present PCSK9 to the LDL receptor
    Gustafsen, Camilla
    Olsen, Ditte
    Vilstrup, Joachim
    Lund, Signe
    Reinhardt, Anika
    Wellner, Niels
    Larsen, Torben
    Andersen, Christian B. F.
    Weyer, Kathrin
    Li, Jin-ping
    Seeberger, Peter H.
    Thirup, Soren
    Madsen, Peder
    Glerup, Simon
    NATURE COMMUNICATIONS, 2017, 8
  • [39] Key aspects of PCSK9 inhibition beyond LDL lowering
    Ramin-Mangata, Stephane
    Blanchard, Valentin
    Lambert, Gilles
    CURRENT OPINION IN LIPIDOLOGY, 2018, 29 (06) : 454 - 459
  • [40] PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulum
    Strom, Thea Bismo
    Tveten, Kristian
    Leren, Trond R.
    BIOCHEMICAL JOURNAL, 2014, 457 : 99 - 105
12345